Persistence of hepatitis A virus antibodies after primary immunization and response to revaccination in children and adolescents with perinatal HIV exposure
暂无分享,去创建一个
R. Succi | M. Miyamoto | D. Machado | A. Gouvêa | F. D. do Carmo | S. Pessoa | S. Beltrão | M. M. Pinto
[1] F. Matin,et al. Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[2] C. Antoniou,et al. Hepatitis A vaccination and immunological parameters in HIV-infected patients. , 2013, Viral immunology.
[3] Felipe García,et al. Factors associated with the immune response to hepatitis A vaccination in HIV-infected patients in the era of highly active antiretroviral therapy. , 2013, Vaccine.
[4] B. McMahon,et al. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10‐year follow‐up , 2012, Hepatology.
[5] M. Wallace,et al. Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults. , 2011, The Journal of infectious diseases.
[6] J. Wood,et al. Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic status. , 2011, Vaccine.
[7] R. Palacios,et al. Impact of Acute Hepatitis A Virus (HAV) Infection on HIV Viral Load in HIV-Infected Patients and Influence of HIV Infection on Acute HAV Infection , 2011, Journal of the International Association of Physicians in AIDS Care.
[8] W. Moss,et al. Do children infected with HIV receiving HAART need to be revaccinated? , 2010, The Lancet. Infectious diseases.
[9] Guo‐zhang Xu,et al. Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children. , 2010, Vaccine.
[10] L. Aurpibul,et al. Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Paige L. Williams,et al. Declines in Mortality Rates and Changes in Causes of Death in HIV-1-Infected Children During the HAART Era , 2010, Journal of acquired immune deficiency syndromes.
[12] N. Hearst,et al. CONTINUING IMPROVEMENT IN SURVIVAL FOR CHILDREN WITH ACQUIRED IMMUNODEFICIENCY SYNDROME IN BRAZIL , 2009, The Pediatric infectious disease journal.
[13] Philimon N. Gona,et al. Virologic and Immunologic Correlates With the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on Highly Active Antiretroviral Treatment , 2009, Journal of acquired immune deficiency syndromes.
[14] P. Palma,et al. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children , 2009, Proceedings of the National Academy of Sciences.
[15] W. Borkowsky,et al. Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy. , 2008, The Journal of infectious diseases.
[16] P. Vial,et al. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[17] W. Powderly,et al. Predictors of immunity after hepatitis A vaccination in HIV‐infected persons , 2007, Journal of viral hepatitis.
[18] B. McMahon,et al. Immunogenicity of an Inactivated Hepatitis A Vaccine in Infants and Young Children , 2007, The Pediatric infectious disease journal.
[19] É. Ono,et al. Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] D. M. Machado,et al. Prevalência de anticorpos contra o vírus da hepatite A em crianças e adolescentes expostos e/ou infectados pelo HIV , 2005 .
[21] R. Succi,et al. [The prevalence of hepatitis A antibodies in HIV exposed and/or infected children and adolescents]. , 2005, Jornal de pediatria.
[22] A. Poirier,et al. Prolonged hepatitis A infection in an HIV‐1 seropositive patient , 2002, Journal of medical virology.
[23] S. Antinori,et al. Persisting HIV-1 Replication Triggered by Acute Hepatitis a Virus Infection , 2000, Antiviral therapy.
[24] Henry Nider,et al. Report of the Committee on Infectious Diseases , 1989 .